Prevalence and spectrum of pathogenic variants among patients with multiple primary cancers evaluated by clinical characteristics

A Population-Based Study of Genes Previously Implicated in Breast Cancer

(2021) Chunling Hu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Identification and management of pathogenic mutations in BRCA1, BRCA2, and PALB2 in a tumor-only genomic testing program.

(2021) Brittany L. Bychkovsky et al.   JOURNAL OF CLINICAL ONCOLOGY

Uptake of Family-Specific Mutation Genetic Testing Among Relatives of Patients with Ovarian Cancer with BRCA1 or BRCA2 Mutation

(2020) Go Woon Jeong et al.   Cancer Research and Treatment

Older adult participation in cancer clinical trials: A systematic review of barriers and interventions

(2020) Mina S. Sedrak et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Barriers and facilitators for cascade testing in genetic conditions: a systematic review

(2020) Swetha Srinivasan et al.   EUROPEAN JOURNAL OF HUMAN GENETICS

Identification of Germline Mutations in Melanoma Patients with Early Onset, Double Primary Tumors, or Family Cancer History by NGS Analysis of 217 Genes

(2020) Lenka Stolarova et al.   Biomedicines

Association of First Primary Cancer With Risk of Subsequent Primary Cancer Among Survivors of Adult-Onset Cancers in the United States

(2020) Hyuna Sung et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Assessment of Trends in Second Primary Cancers in Patients With Metastatic Melanoma From 2005 to 2016

(2020) Weiye Deng et al.   JAMA Network Open

Comparison of Universal Genetic Testing vs Guideline-Directed Targeted Testing for Patients With Hereditary Cancer Syndrome

(2020) N. Jewel Samadder et al.   JAMA Oncology

Recent advances in Lynch syndrome

(2019) Leah H. Biller et al.   Familial Cancer

Risk of subsequent primary neoplasms in survivors of adolescent and young adult cancer (Teenage and Young Adult Cancer Survivor Study): a population-based, cohort study

(2019) Chloe J Bright et al.   LANCET ONCOLOGY

Are rare cancer survivors at elevated risk of subsequent new cancers?

(2019) Dianne M. Finkelstein et al.   BMC CANCER

Breast cancer-specific survival by age: Worse outcomes for the oldest patients

(2018) Rachel A. Freedman et al.   CANCER

Receipt of Guideline-Concordant Care Among Older Women With Stage I–III Breast Cancer: A Population-Based Study

(2018) Traci LeMasters et al.   Journal of the National Comprehensive Cancer Network

Germline mutations in candidate predisposition genes in individuals with cutaneous melanoma and at least two independent additional primary cancers

(2018) Antonia L. Pritchard et al.   PLoS One

Age and perceived risks and benefits of preventive genomic screening

(2017) Margaret Waltz et al.   GENETICS IN MEDICINE

Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results

(2016) Mary Pritzlaff et al.   BREAST CANCER RESEARCH AND TREATMENT

Counselling framework for moderate-penetrance cancer-susceptibility mutations

(2016) Nadine Tung et al.   Nature Reviews Clinical Oncology

Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer

(2016) Colin C. Pritchard et al.   NEW ENGLAND JOURNAL OF MEDICINE

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology

(2015) Sue Richards et al.   GENETICS IN MEDICINE

CHEK2mutations and the risk of papillary thyroid cancer

(2015) Monika Siołek et al.   INTERNATIONAL JOURNAL OF CANCER

BRCA1andBRCA2germline mutations are frequently demonstrated in both high-risk pancreatic cancer screening and pancreatic cancer cohorts

(2014) Aimee L. Lucas et al.   CANCER

BRCA1andBRCA2mutations and the risk for colorectal cancer

(2014) V. Sopik et al.   CLINICAL GENETICS

GermlineTP53Mutations and the Changing Landscape of Li-Fraumeni Syndrome

(2014) Junne Kamihara et al.   HUMAN MUTATION

Colorectal Cancer Resections in the Aging US Population

(2014) Mehraneh D. Jafari et al.   JAMA Surgery

Excess of extracolonic non-endometrial multiple primary cancers in MSH2 germline mutation carriers over MLH1

(2013) Kevin M. Lin-Hurtubise et al.   JOURNAL OF SURGICAL ONCOLOGY

Prevalence ofBRCA1andBRCA2mutations in Ashkenazi Jewish families with breast and pancreatic cancer

(2011) Zsofia K. Stadler et al.   CANCER

Improvement in Breast Cancer Outcomes Over Time: Are Older Women Missing Out?

(2011) Benjamin D. Smith et al.   JOURNAL OF CLINICAL ONCOLOGY

Uptake of predictive testing among relatives of BRCA1 and BRCA2 families: a multicenter study in northeastern Spain

(2009) Judit Sanz et al.   Familial Cancer